市場調查報告書
商品編碼
1470753
電子醫療/生物電子醫療市場:按產品、設備、應用和最終用戶分類 - 2024-2030 年全球預測Electroceuticals/Bioelectric Medicine Market by Product, Device, Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年電子醫療/生物電子醫療市場規模為250.6億美元,2024年達270.5億美元,2030年預計將達432.8億美元,複合年成長率為8.11%。
電藥或生物電醫學是指使用電脈衝調節人體神經迴路作為藥物替代品的治療方法。這種創新方法利用神經系統控制身體器官功能的先天能力,影響各種生理和病理狀況。電療的基本原理是精確地向特定神經發送電訊號以調節其活動並治療各種疾病。老年人口的增加、心臟疾病和神經系統疾病的盛行率以及對非侵入性治療的偏好正在推動電療和生物電製藥市場的成長。然而,與電療相關的技術複雜性阻礙了其普及。生物電醫學領域不斷的技術創新,例如設備的小型化和電池壽命的提高,以及生物電醫學的進步使個性化治療計劃成為可能,有利於電醫學或生物電醫學市場的擴大,為您提供了巨大的機會。
主要市場統計 | |
---|---|
基準年[2023] | 250.6億美元 |
預測年份 [2024] | 270.5億美元 |
預測年份 [2030] | 432.8億美元 |
複合年成長率(%) | 8.11% |
產品由於心血管疾病的流行,對心臟心律調節器和植入式心臟整流去顫器的需求不斷增加
心臟心律調節器和植入式心臟整流去顫器對於心律不整的治療至關重要。當心臟的自然心律調節器失效時,心律調節器可以維持適當的心率。植入式心臟整流去顫器(ICD) 是一種心臟心律調節器,是一種先進的設備,可以透過電擊糾正危及生命的心律不整並防止心因性猝死。人工電子耳是一種電子醫療設備,可以取代受損內耳的功能。人工電子耳繞過內耳受損的毛細胞,向大腦發送聲音訊號,對於重度聽力損失患者恢復聽力至關重要。深層腦部刺激器主要用於治療神經系統疾病,如帕金森氏症、肌張力不全症和自發性震顫,並向大腦的特定部位發送電脈衝。視網膜植入是為因老齡化黃斑部病變(AMD)和色素性視網膜炎等視網膜疾病而視力嚴重受損的人製造的,它們通過替代眼睛中受損的感光細胞來發揮作用。視網膜植入透過將入射光轉換成電訊號並將其發送到大腦來部分恢復視力。脊髓刺激設備旨在緩解慢性疼痛。脊髓刺激設備使用低壓電流在疼痛訊號到達大腦之前阻止它們。迷走神經刺激設備針對迷走神經,迷走神經從大腦穿過頸部到達腹部,調節許多身體功能。迷走神經刺激設備主要用於治療癲癇和憂鬱症,分別向神經發送電脈衝以穩定異常的腦電活動和情緒。
應用:擴大電療療法用於治療慢性疼痛的應用
電製劑透過有針對性的電刺激調節心律,為治療心律不整提供了一種有前景的方法。植入式心臟整流去顫器(ICD) 和心律調節器等設備提供精確的電脈衝以維持或恢復正常心律,是治療的基石。脊髓刺激 (SCS) 和經皮神經電刺激 (TENS) 等電療法已顯示出對慢性疼痛治療的功效。這些方法的作用是在疼痛訊號到達大腦之前改變它們,為對藥物治療反應不佳的患者提供另一種選擇。在癲癇治療中,迷走神經刺激設備(VNS)等向迷走神經發送週期性電脈衝的裝置可以幫助減少對藥物治療無反應的患者癲癇發作的嚴重程度和頻率,具有顯著的效用。電療藥物在帕金森氏症治療方面取得了突破,特別是深部腦部刺激(DBS)。透過向大腦的特定部位提供電刺激,DBS 有助於控制帕金森氏症的運動症狀,例如震顫、僵硬和移動困難。視網膜假體或視網膜植入是生物電子醫學的先進型態,可為色素性視網膜炎患者型態視力恢復。這些設備透過將外部光轉換為電訊號並將其發送到大腦來為用戶提供視覺。人工電子耳對於感音性聽障患者來說是一項重要的電生理應用。這些設備繞過耳朵中受損的毛細胞,直接刺激聽覺神經,讓您感知聲音並大大提高您的溝通能力。
區域洞察
由於先進的醫療基礎設施、對研發的重視以及高昂的醫療成本,美洲的電子醫療/生物電子醫療市場正在成長。心血管疾病、神經系統疾病和糖尿病等慢性疾病在美洲很普遍,增加了電療解決方案的需求。此外,在美國,醫療機構和高科技公司之間的合作正在推動創新和更先進、更有針對性的電療治療方法的開發。由於醫療基礎設施的迅速改善、可支配收入的增加以及對先進醫療保健意識的不斷增強,亞太地區電子醫療/生物電子醫療市場正在不斷成長。亞太地區人口老化和慢性病患者較多,是電療的重要應用領域。歐洲、中東和非洲地區是一個多元化且不斷發展的電子醫療/生物電子醫療市場,其特徵是歐洲成熟的醫療保健系統以及中東和非洲的新興市場。憑藉嚴格的法律規範、高醫療標準和對研究的高度重視,歐洲在電療領域的發展中發揮關鍵作用。在中東,醫療基礎設施投資不斷擴大,對尖端醫療技術的興趣不斷增加。由於人們對非藥物治療選擇的認知不斷提高以及改善醫療保健系統的努力,非洲地區顯示出成長潛力。
FPNV定位矩陣
FPNV定位矩陣對於評估電子醫療/生物電子醫療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對電子醫療/生物電子醫療市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 電子醫療/生物電子醫療市場的市場規模與預測是多少?
2.在電子醫療/生物電子醫療市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.電子醫療/生物電子醫療市場的技術趨勢和法規結構是什麼?
4.電子醫療/生物電子醫療市場主要廠商的市場佔有率是多少?
5. 進入電子醫療/生物電子醫療市場的適當型態和策略手段是什麼?
[194 Pages Report] The Electroceuticals/Bioelectric Medicine Market size was estimated at USD 25.06 billion in 2023 and expected to reach USD 27.05 billion in 2024, at a CAGR 8.11% to reach USD 43.28 billion by 2030.
Electroceuticals, or bioelectric medicine, refer to a therapeutic modality that uses electrical impulses to modulate the body's neural circuits as an alternative to pharmaceuticals. This innovative approach exploits the nervous system's inherent capability to govern the body's organ functions, influencing various physiological and pathological conditions. The fundamental principle behind electroceuticals involves precisely delivering electrical signals to specific nerves, aiming to adjust their activity to treat various medical conditions. The growing elderly population, the prevalence of cardiac and neurological disorders, and the rising preference for non-invasive treatments drive the growth of the electroceuticals or bioelectric medicine market. However, the technological complexities associated with electroceuticals hinder their adoption. The ongoing innovation in bioelectric medicine, including the miniaturization of devices and improvements in battery life, and advancements in bioelectric medicine that allow for personalized treatment plans offer lucrative opportunities for the expansion of the electroceuticals or bioelectric medicine market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.06 billion |
Estimated Year [2024] | USD 27.05 billion |
Forecast Year [2030] | USD 43.28 billion |
CAGR (%) | 8.11% |
Product: Increasing need for cardiac pacemakers and implantable cardioverter defibrillators owing to the prevalence of cardiovascular diseases
Cardiac pacemakers & implantable cardioverter defibrillator devices are critical in managing heart rhythm disorders. Pacemakers maintain an adequate heart rate when the heart's natural pacemaker is dysfunctional. Implantable cardioverter defibrillators (ICDs) are advanced devices that pace the heart and deliver shocks to correct life-threatening arrhythmias, thus preventing sudden cardiac death. Cochlear implants are electronic medical devices replacing the function of the damaged inner ear. Cochlear implants bypass damaged hair cells of the inner ear for providing sound signals to the brain, and are integral in restoring hearing in individuals with profound hearing loss. Deep brain stimulators are utilized primarily to treat neurological conditions such as Parkinson's disease, dystonia, and essential tremors, and they send electrical pulses to specific parts of the brain. Retinal implants are tailored for individuals with severe vision loss due to retinal diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa; retinal implants work by substituting the damaged photoreceptor cells in the eye. Retinal implants convert incoming light into electrical signals, which are then sent to the brain, thereby partially restoring vision. Spinal cord stimulators are designed to alleviate chronic pain; spinal cord stimulators emit low-voltage electrical currents to interrupt pain signals before reaching the brain. Vagus nerve stimulator devices target the vagus nerve, running from the brain through the neck and into the abdomen, modulating numerous body functions. Vagus nerve stimulators are primarily used to treat epilepsy and depression, delivering electrical impulses to the nerve to stabilize abnormal electrical brain activity and mood, respectively.
Application: Growing adoption of electroceuticals to manage chronic pain conditions
Electroceuticals offer a promising approach to managing arrhythmias by modulating heart rhythms through targeted electrical stimulation. Devices, including implantable cardioverter defibrillators (ICDs) and pacemakers, have become cornerstone treatments, providing precise electrical impulses to maintain or restore normal heart rhythm. In chronic pain management, electroceutical interventions such as spinal cord stimulation (SCS) and transcutaneous electrical nerve stimulation (TENS) have shown effectiveness. These methods work by altering pain signals before they reach the brain, offering an alternative for patients who might not respond well to pharmacological therapies. In epilepsy treatment, devices such as the vagus nerve stimulator (VNS) demonstrate significant utility by regularly delivering electrical impulses to the vagus nerve, helping reduce the severity and frequency of seizures in patients unresponsive to medication. Electroceuticals have made strides in Parkinson's disease management, notably through deep brain stimulation (DBS). By delivering electrical stimuli to specific areas in the brain, DBS can help control motor symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty moving. An advanced form of bioelectric medicine, the artificial retina or retinal implants offer a form of sight restoration for individuals with retinitis pigmentosa. These devices convert external light into electrical signals, which are then sent to the brain, helping to provide the user with a form of visual perception. Cochlear implants represent a pivotal electroceutical application in sensorineural hearing loss cases. These devices bypass damaged hair cells within the ear to directly stimulate the auditory nerve, allowing individuals to perceive sound and significantly improving communication abilities.
Regional Insights
The Americas experiences growth in the electroceuticals/bioelectric medicine market, attributed to advanced healthcare infrastructure, strong emphasis on research and development, and high healthcare expenditure. The prevalence of chronic diseases, including cardiovascular disorders, neurological ailments, and diabetes in the Americas, fuels the need for electroceutical solutions. Additionally, partnerships between medical institutions and tech companies in the U.S. foster innovation and facilitate the development of more sophisticated and targeted electroceutical therapies. The Asia-Pacific region's electroceuticals/bioelectric medicine market is growing, driven by rapidly improving healthcare infrastructure, increasing disposable incomes, and a growing awareness of advanced medical treatments. The Asia-Pacific region's growing aging population presents a substantial patient pool for chronic diseases and significant electroceutical application areas. The EMEA region presents a diverse and evolving market for electroceuticals/bioelectric medicine, characterized by well-established healthcare systems in Europe and emerging markets in the Middle East and Africa. With its stringent regulatory framework, high healthcare standards, and a strong emphasis on research, Europe plays a crucial role in advancing the electroceutical field. The Middle East witnesses growing investments in healthcare infrastructure and an increasing inclination toward advanced medical technologies. The African region showcases the potential for growth due to rising awareness of non-pharmaceutical treatment options and efforts to improve healthcare systems.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Electroceuticals/Bioelectric Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Electroceuticals/Bioelectric Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Electroceuticals/Bioelectric Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Bioinduction Ltd., BIOTRONIK SE & Co. KG, BioWave Corporation, Boston Scientific Corporation, CEFALY Technology sprl, Cochlear Limited, electroCore, Inc., Galvani Bioelectronics by GSK PLC, Gimer Medical Co., Ltd., LivaNova PLC, MED-EL Elektromedizinische Gerate GmbH, Medtronic PLC, NeuroPace, Inc., Nevro Corp., Oticon Medical, Second Sight Medical Products, Inc., and Sonova Holding AG.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Electroceuticals/Bioelectric Medicine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Electroceuticals/Bioelectric Medicine Market?
3. What are the technology trends and regulatory frameworks in the Electroceuticals/Bioelectric Medicine Market?
4. What is the market share of the leading vendors in the Electroceuticals/Bioelectric Medicine Market?
5. Which modes and strategic moves are suitable for entering the Electroceuticals/Bioelectric Medicine Market?